You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 013263


✉ Email this page to a colleague

« Back to Dashboard


NDA 013263 describes VALIUM, which is a drug marketed by Roche and Waylis Therap and is included in two NDAs. It is available from two suppliers. Additional details are available on the VALIUM profile page.

The generic ingredient in VALIUM is diazepam. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for 013263
Tradename:VALIUM
Applicant:Waylis Therap
Ingredient:diazepam
Patents:0
Suppliers and Packaging for NDA: 013263
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VALIUM diazepam TABLET;ORAL 013263 NDA Roche Laboratories Inc. 0140-0004 0140-0004-01 1 BOTTLE, PLASTIC in 1 CARTON (0140-0004-01) / 100 TABLET in 1 BOTTLE, PLASTIC
VALIUM diazepam TABLET;ORAL 013263 NDA Roche Laboratories Inc. 0140-0005 0140-0005-01 1 BOTTLE, PLASTIC in 1 CARTON (0140-0005-01) / 100 TABLET in 1 BOTTLE, PLASTIC

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 006

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 013263

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-002 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-006 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-004 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.